| PERIOD ENDING | 3-Oct-09 | 11-Jul-09 | 21-Mar-09 | 27-Dec-08 | | Total Revenue | 26,358 | 35,641 | 24,958 | 32,927 | | Cost of Revenue | 18,558 | 24,579 | 17,096 | 26,544 | | | Gross Profit | 7,800 | 11,062 | 7,862 | 6,383 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,571 | 8,748 | 8,023 | 9,743 | | Non Recurring |
-
|
-
|
-
| 2,623 | | Others | 617 | 940 | 467 | 375 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 612 | 1,374 | (628) | (6,358) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 966 | 47 | 184 | (178) | | Earnings Before Interest And Taxes | 48 | 1,421 | (444) | (6,536) | | Interest Expense | (900) | 658 | 242 | 326 | | Income Before Tax | 948 | 763 | (686) | (6,862) | | Income Tax Expense | 330 | 397 | (247) | (2,283) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 618 | 366 | (439) | (4,579) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 618 | 366 | (439) | (4,579) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $618 | $366 | ($439) | ($4,579) |
|
0.51% Nasdaq 
Income Statement
